Allos AI
Health
· Headquartered in N/A 🌍
Track Allos AI
— get Health deals in free daily digest
Overview
Allos AI has secured $5 million in seed financing to develop its innovative 'glass-box' causal AI platform aimed at reformulating complex generic drugs. This funding addresses the need for lower-risk methods to enhance the delivery and tolerance of established medications over extended use, appealing to developers and manufacturers in the pharmaceutical industry.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Allos AI has secured $5 million in seed financing to develop its innovative 'glass-box' causal AI platform aimed at reformulating complex generic drugs. This funding addresses the need for lower-risk methods to enhance the delivery and tolerance of established medications over extended use, appealing to developers and manufacturers in the pharmaceutical industry.
More Health Deals
Market Map
View thousands of companies by category in our market map:
